[Back to Issue 9 ToC] [Back to Journal Contents] [Back to Biochemistry (Moscow) Home page]
[View Full Article] [Download Reprint (PDF)]

REVIEW: Molecular Pathogenesis in Huntington’s Disease

S. N. Illarioshkin1,a,b*, S. A. Klyushnikov1,2, V. A. Vigont2,c, Yu. A. Seliverstov1, and E. V. Kaznacheyeva2,c

1Research Center of Neurology, 125367 Moscow, Russia

2Institute of Cytology, Russian Academy of Sciences, 194064 St. Petersburg, Russia

* To whom correspondence should be addressed.

Received May 21, 2018; Revision received May 31, 2018
Huntington’s disease (HD) is a severe autosomal dominant neurodegenerative disorder characterized by a combination of motor, cognitive, and psychiatric symptoms, atrophy of the basal ganglia and the cerebral cortex, and inevitably progressive course resulting in death 5-20 years after manifestation of its symptoms. HD is caused by expansion of CAG repeats in the HTT gene, which leads to pathological elongation of the polyglutamine tract within the respective protein – huntingtin. In this review, we present a modern view on molecular biology of HD as a representative of the group of polyglutamine diseases, with an emphasis on conformational changes of mutant huntingtin, disturbances in its cellular processing, and proteolytic stress in degenerating neurons. Main pathogenetic mechanisms of neurodegeneration in HD are discussed in detail, such as systemic failure of transcription, mitochondrial dysfunction and suppression of energy metabolism, abnormalities of cytoskeleton and axonal transport, microglial inflammation, decrease in synthesis of brain-derived neurotrophic factor, etc.
KEY WORDS: Huntington’s disease, molecular pathogenesis, polyglutamine expansion, proteolytic stress, transcription dysregulation, mitochondria

DOI: 10.1134/S0006297918090043